PedAM
Pediatric Disease Annotations & Medicines
| Disease | renal cell carcinoma |
| Phenotype | C0020538|hypertension |
| Sentences | 6 |
| PubMedID- 24595903 | hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase iii axis trial. |
| PubMedID- 25393631 | Relative to other racial/ethnic groups, blacks had the highest proportion of renal cell carcinoma incidence attributable to hypertension and chronic kidney disease (combined, par = 37%; hypertension only, par = 27%; chronic kidney disease, par = 10%). |
| PubMedID- 23966283 | Objectives: this study evaluated whether particular diabetes mellitus (dm), hyperlipidemia, or hypertension pharmacotherapy was associated with improved renal cell carcinoma (rcc) outcomes in diabetics with emergent rcc. |
| PubMedID- 24621095 | A significantly higher incidence of hypertension was noted in patients with renal cell carcinoma (rcc) compared with those with non-rcc malignancies (all-grade: 24.9% [95% ci, 19.7%-30.1%] vs 15.7%[95% ci, 12.1%-19.3%]; p<.05; high-grade:8.6% [95% ci, 6.0%-11.2%] vs 1.8% [95% ci, 0.9%-2.6%]; p<.05). |
| PubMedID- 26081424 | Association of hypertension and obesity with renal cell carcinoma risk: a report from the shanghai men's and women's health studies. |
| PubMedID- 23665301 | Conclusions: we identified a significant association of renal cell carcinoma with obesity, smoking, hypertension, renal disease and viral hepatitis. |
Page: 1